{"id":"https://openalex.org/W391817458","doi":null,"title":"Efficacy and Pharmacokinetics of SCYX-7158 (AN5568): a Novel and Potent Oxaborole-6-Carboxamide Selected as a Pre-Clinical Candidate for Once-Daily Oral Treatment for Stage 2 Human African Trypanosomiasis.","display_name":"Efficacy and Pharmacokinetics of SCYX-7158 (AN5568): a Novel and Potent Oxaborole-6-Carboxamide Selected as a Pre-Clinical Candidate for Once-Daily Oral Treatment for Stage 2 Human African Trypanosomiasis.","publication_year":2009,"publication_date":"2009-01-01","ids":{"openalex":"https://openalex.org/W391817458","mag":"391817458"},"language":"en","primary_location":{"id":"mag:391817458","doi":null,"is_oa":false,"landing_page_url":"https://assets.publishing.service.gov.uk/media/57a08b5ce5274a27b2000adb/scyx_7158_against_HAT_poster.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Robert M. J. Jacobs","orcid":"https://orcid.org/0000-0002-4587-6140","observed_orcids":["https://orcid.org/0000-0002-4587-6140"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert M. J. Jacobs","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4587-6140","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058337790","display_name":"Bakela Nare","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bakela Nare","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072724821","display_name":"Stephen A. Wring","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen A. Wring","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"C. J. Bacchi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. J. Bacchi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025257031","display_name":"Regina P. Brun","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Regina P. Brun","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113831232","display_name":"Jake J Plattner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J.J. Plattner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060340346","display_name":"Beth Beaudet","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Beth Beaudet","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055078865","display_name":"Tana Bowling","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tana Bowling","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004914171","display_name":"D. Chen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. Chen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033601718","display_name":"Yvonne R. Freund","orcid":"https://orcid.org/0000-0003-0025-1400","observed_orcids":["https://orcid.org/0000-0003-0025-1400"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yvonne R. Freund","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0025-1400","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066257193","display_name":"Eric Gaukel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eric Gaukel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075975247","display_name":"Matthew Jenks","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matthew Jenks","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107309323","display_name":"Moacir Kaiser","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Moacir Kaiser","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008529631","display_name":"Luke Mercer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Luke Mercer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028382094","display_name":"A. Noe","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Noe","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111514408","display_name":"Matt Orr","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matt Orr","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024917655","display_name":"Robin Parham","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robin Parham","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078940945","display_name":"Cindy Rewerts","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cindy Rewerts","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055714430","display_name":"J. Sligar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Sligar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055249552","display_name":"Nigel Yarlett","orcid":"https://orcid.org/0000-0002-7493-4346","observed_orcids":["https://orcid.org/0000-0002-7493-4346"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nigel Yarlett","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-7493-4346","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5109247462","display_name":"R. Don","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Don","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.05501173,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10890","display_name":"Trypanosoma species research and implications","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10890","display_name":"Trypanosoma species research and implications","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10296","display_name":"Vector-borne infectious diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2405","display_name":"Parasitology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10823","display_name":"Research on Leishmaniasis Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trypanocidal-drugs","display_name":"trypanocidal drugs","score":0.7490000128746033},{"id":"https://openalex.org/keywords/human-african-trypanosomiasis","display_name":"sleeping sickness","score":0.8949999809265137},{"id":"https://openalex.org/keywords/trypanosoma-brucei-rhodesiense","display_name":"Trypanosoma brucei rhodesiense","score":0.9390000104904175},{"id":"https://openalex.org/keywords/trypanosoma-brucei-gambiense","display_name":"Trypanosoma brucei gambiense","score":1.0},{"id":"https://openalex.org/keywords/blood-testis-barrier","display_name":"blood-testis barrier","score":0.8920000195503235},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8939999938011169},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.6990000009536743},{"id":"https://openalex.org/keywords/adme-properties","display_name":"ADME properties","score":0.5649999976158142},{"id":"https://openalex.org/keywords/lead-optimization","display_name":"lead optimization","score":0.4790000021457672},{"id":"https://openalex.org/keywords/recrudescence","display_name":"recrudescence","score":0.652999997138977}],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8150033950805664},{"id":"https://openalex.org/C69366308","wikidata":"https://www.wikidata.org/wiki/Q2272286","display_name":"ADME","level":3,"score":0.7691042423248291},{"id":"https://openalex.org/C2778792689","wikidata":"https://www.wikidata.org/wiki/Q203133","display_name":"African trypanosomiasis","level":3,"score":0.7670280933380127},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7497906684875488},{"id":"https://openalex.org/C2779502636","wikidata":"https://www.wikidata.org/wiki/Q33244","display_name":"Trypanosoma brucei","level":3,"score":0.6745744943618774},{"id":"https://openalex.org/C181389837","wikidata":"https://www.wikidata.org/wiki/Q461809","display_name":"Bioavailability","level":2,"score":0.5614498853683472},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5588130354881287},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.503452718257904},{"id":"https://openalex.org/C110121322","wikidata":"https://www.wikidata.org/wiki/Q865811","display_name":"Distribution (mathematics)","level":2,"score":0.4276910424232483},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.42674195766448975},{"id":"https://openalex.org/C139254425","wikidata":"https://www.wikidata.org/wiki/Q1332167","display_name":"Volume of distribution","level":3,"score":0.4238932430744171},{"id":"https://openalex.org/C2776684476","wikidata":"https://www.wikidata.org/wiki/Q7848571","display_name":"Trypanocidal agent","level":4,"score":0.42208003997802734},{"id":"https://openalex.org/C2778143080","wikidata":"https://www.wikidata.org/wiki/Q2443552","display_name":"Trypanosomiasis","level":2,"score":0.3548685312271118},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.32704126834869385},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2212488055229187},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.09459277987480164},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C134306372","wikidata":"https://www.wikidata.org/wiki/Q7754","display_name":"Mathematical analysis","level":1,"score":0.0},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:391817458","doi":null,"is_oa":false,"landing_page_url":"https://assets.publishing.service.gov.uk/media/57a08b5ce5274a27b2000adb/scyx_7158_against_HAT_poster.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2007025107","https://openalex.org/W2130720347","https://openalex.org/W222073337","https://openalex.org/W2097174087","https://openalex.org/W2275665357","https://openalex.org/W2610863995","https://openalex.org/W2092364932","https://openalex.org/W2550786682","https://openalex.org/W2213305331","https://openalex.org/W4388694814"],"abstract_inverted_index":{"In":[0,130,152,240,246],"vitro":[1,74,105,241],"activity":[2],"against":[3,75],"Trypanosoma":[4,79],"brucei":[5],"strains":[6,77],"Summary":[7],"SCYX-7158,":[8],"a":[9,26,35,41,172,178,231],"3,3-dimethyloxaborole-6-carboxamide,":[10],"is":[11,71,90,138,162],"distinguished":[12],"from":[13],"earlier":[14],"trypanocidal":[15],"oxaboroles":[16],"by":[17],"enhanced":[18],"pharmacokinetic":[19,68,154],"and":[20,67,85,89,96,103,123,177,194,196],"CNS":[21,121,255],"disposition":[22],"properties":[23,107],"allowing":[24],"for":[25,127,234],"once":[27],"per":[28],"day":[29],"(QD)":[30],"oral":[31],"dosing":[32],"regimen":[33],"at":[34,141],"markedly":[36],"lower":[37,216],"efficacious":[38,91],"dose":[39],"in":[40,73,92,104,165,205,251],"Stage":[42,94,97,134,237,253,258],"2":[43,98,135,238,254],"murine":[44,99,133],"Human":[45],"African":[46],"Trypanosomiasis":[47],"(HAT)":[48],"model.":[49],"The":[50],"discovery":[51],"of":[52,58,78,108,156,180,218,224,236,244,249,264],"SCYX-7158":[53,70,109,137,157,226,245,250,265],"was":[54],"achieved":[55],"through":[56],"application":[57],"integrated":[59],"lead":[60],"optimization":[61],"strategies":[62],"across":[63],"medicinal":[64],"chemistry,":[65],"parasitology":[66],"disciplines.":[69],"active":[72],"relevant":[76],"brucei,":[80],"including":[81],"T.":[82,86],"b.":[83,87],"rhodesiense":[84],"gambiense":[88],"both":[93],"1":[95,259],"HAT":[100],"models.":[101],"Physicochemical":[102],"ADME":[106],"are":[110],"consistent":[111],"with":[112,124,221],"the":[113,160,198],"compound":[114,161],"being":[115],"orally":[116,140],"available,":[117],"metabolically":[118],"stable,":[119],"readily":[120,190],"permeable":[122],"low":[125,144,168],"risk":[126],"drug-drug":[128],"interactions.":[129],"an":[131],"ongoing":[132],"study,":[136],"effective":[139],"doses":[142],"as":[143,145,230],"12.5":[146],"mg/kg":[147],"(QD":[148],"x":[149],"7":[150],"days).":[151],"vivo":[153,247],"characterization":[155],"demonstrates":[158],"that":[159,182],"highly":[163],"bioavailable":[164],"rodents,":[166],"has":[167,227],"intravenous":[169],"plasma":[170],"clearance,":[171],"24":[173],"hr":[174],"elimination":[175],"half-life":[176],"volume":[179],"distribution":[181],"indicates":[183],"good":[184],"tissue":[185],"distribution.":[186],"Most":[187],"importantly,":[188],"SCYX7158":[189],"distributes":[191],"into":[192],"brain":[193],"CSF":[195],"crosses":[197],"blood-testicular":[199],"barrier":[200],"to":[201],"achieve":[202],"therapeutically-relevant":[203],"concentrations":[204],"potential":[206],"trypanosomal":[207],"sanctuary":[208],"sites.":[209],"Based":[210],"on":[211],"these":[212],"properties,":[213],"which":[214],"promise":[215],"rates":[217],"recrudescence":[219],"than":[220],"current":[222],"standard":[223],"care,":[225],"been":[228],"selected":[229],"pre-clinical":[232],"candidate":[233],"treatment":[235],"HAT.":[239],"ADMET":[242],"profile":[243],"PK":[248],"rodents":[252],"Model":[256,261],"(Chronic)":[257],"non-CNS":[260],"(Acute)":[262],"Synthesis":[263]},"counts_by_year":[{"year":2020,"cited_by_count":1}],"updated_date":"2026-10-02T10:15:12.560889","created_date":"2016-06-24T00:00:00"}